Unravel Biosciences licenses Wyss Institute platform
The company is developing therapeutics for rare genetic diseases affecting the central nervous system, starting with Rett syndrome...
Source: globenewswire.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Lead Staff Engineer. Real-time updates on events, politics, business and more.